Valerie S. Hawthorne, Ph.D. - Publications
Affiliations: | 2006 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Oncology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Li S, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D. Abstract 262: Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through NF-κB activation Cancer Research. 70: 262-262. DOI: 10.1158/1538-7445.Am10-262 | 0.632 | |||
2009 | Li SH, Hawthorne VS, Neal CL, Sanghera S, Xu J, Yang J, Guo H, Steeg PS, Yu D. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Research. 69: 9163-8. PMID 19951994 DOI: 10.1158/0008-5472.Can-09-2483 | 0.632 | |||
2009 | Hawthorne VS, Huang WC, Neal CL, Tseng LM, Hung MC, Yu D. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. Molecular Cancer Research : McR. 7: 592-600. PMID 19372587 DOI: 10.1158/1541-7786.Mcr-08-0316 | 0.547 | |||
2005 | Younes MN, Yigitbasi OG, Park YW, Kim SJ, Jasser SA, Hawthorne VS, Yazici YD, Mandal M, Bekele BN, Bucana CD, Fidler IJ, Myers JN. Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Cancer Research. 65: 4716-27. PMID 15930290 DOI: 10.1158/0008-5472.Can-04-4196 | 0.355 | |||
2004 | Hawthorne VS, Yu D. PI3K: Missense Mutation Motivates Malignancy. Cancer Biology & Therapy. 3: 776-7. PMID 15280668 DOI: 10.4161/Cbt.3.8.1031 | 0.498 | |||
Show low-probability matches. |